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Introduction
Cell stage–specific kinases are important for the progression of 
mitosis. These kinases play a role in specific pathways to en-
sure that chromosomes segregate properly to daughter cells to 
prevent aneuploidy. Among the mitotic kinases, Aurora B plays 
a central role in the maintenance of genome stability by activat-
ing the spindle assembly checkpoint in response to improper 
kinetochore–microtubule attachment and tension during early 
mitosis (Lan et al., 2004; Cheeseman et al., 2006; Cimini et 
al., 2006; DeLuca et al., 2006; Pinsky et al., 2006; Welburn et 
al., 2010). Aurora B kinase localizes at the centromere during 
early mitosis, and its centromeric localization is achieved by its 
interaction with other members of the chromosomal passenger 
complex (CPC): INC ENP, Borealin, and Survivin (Adams et 
al., 2000; Kaitna et al., 2000; Gassmann et al., 2004). Several 
mechanisms for CPC recruitment at mitotic centromeres exist 
in eukaryotes (Carmena et al., 2012). Among them, two mech-
anisms rely on the mitosis-specific phosphorylation of histone 
tails. Bub1-dependent phosphorylation of H2A threonine 120 
(serine 121 in fission yeast) allows for its interaction with Shu-
goshin proteins, which can then interact and recruit the CPC by 
binding with Borealin (Kawashima et al., 2010; Yamagishi et 
al., 2010). The other mechanism is the recruitment of CPC to 
the centromere through the activity of histone H3 kinase Haspin, 
which phosphorylates histone H3 at threonine 3 (H3T3) for its 
direct interaction with the BIR domain of Survivin (Kelly et 
al., 2010; Jeyaprakash et al., 2011). A previous study suggested 
that the cohesin-associated factor Pds5 may help target Haspin 
to chromosomes in fission yeast (Yamagishi et al., 2010). How-
ever, the mechanism of how Haspin localizes onto the chromo-
somes to target centromeric histone H3 in vertebrates remains 
unclear. CPC recruitment at mitotic centromeres uses multiple 
molecular mechanisms, suggesting that different signals can 
control specific pathways.
DNA topoisomerase II (TOP2) has a critical role during 
mitosis for resolving tangled genomic DNA by its strand- 
passaging enzymatic reaction (Holm et al., 1985). Inhibition 
of TOP2 activity could activate cell cycle checkpoints, includ-
ing the DNA damage checkpoint, because of double-stranded 
breaks mediated by TOP2 (Nitiss, 2009). A proposed mecha-
nism of TOP2-initiated G2 arrest is the binding of MDC1 to 
the phosphorylated TOP2 C-terminal domain (Luo et al., 2009). 
More recently, Furniss et al. (2013) showed that specific muta-
tions of TOP2 that alter its strand-passaging reaction at specific 
steps could induce a Mad2-dependent delay in mitosis in bud-
ding yeast. Interestingly, this checkpoint activation requires the 
C-terminal domain (CTD) of TOP2, which suggests that TOP2 
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CTD has a critical role in controlling cell cycle progression, 
and the domain could serve as a signal transducer for cell cycle 
checkpoints. Notably, TOP2 has been reported to be involved in 
Aurora B activation, suggesting that TOP2 can control mitotic 
checkpoints via Aurora B (Coelho et al., 2008).
Although TOP2 could be modified with both SUMO1 and 
SUMO2/3, topoisomerase IIα (TOP2A) has been reported to 
be modified primarily by SUMO2/3 during mitosis in Xenopus 
laevis (Mao et al., 2000; Azuma et al., 2003; Agostinho et al., 
2008). Recently, we have shown that SUMOylation of TOP2A 
CTD facilitates novel interaction with DNA damage checkpoint 
adaptor protein Claspin in X.  laevis egg extracts (XEEs; Ryu 
et al., 2015). Claspin binds to Chk1, a kinase known to acti-
vate Aurora B by phosphorylating serine 311 in human cells 
(Kumagai and Dunphy, 2000; Petsalaki et al., 2011). Therefore, 
SUMOylated TOP2A could be involved in Aurora B activation 
by Chk1 recruitment via Claspin. In addition to the potential 
Aurora B regulation by Claspin, we have identified Haspin 
as a binding protein of SUMOylated CTD by comprehensive 
liquid chromatography–tandem mass spectrometry (LC-MS/
MS) analysis. Both Haspin and phosphorylated H3T3 (H3T3p) 
were less abundant on mitotic chromosomes when TOP2A 
SUMOylation was prevented. Robust binding of Haspin to 
SUMOylated TOP2A required Haspin’s SUMO-interacting 
motifs (SIMs) and the phosphorylation of Haspin, and muta-
tions in both T206 and SIMs prevented Haspin from properly 
localizing at mitotic centromeres. Altogether, our results show 
that SUMOylated TOP2A regulates the targeting of active 
Haspin to mitotic centromeres for the phosphorylation of H3T3. 
We propose that this novel mechanism of Haspin recruitment 
mediated by SUMOylated TOP2A CTD may be another mo-
lecular mechanism that regulates the progression of mitosis by 
regulating Aurora B at mitotic centromeres.
Results
SUMOylation contributes to the 
localization of Aurora B kinase on mitotic 
chromosomes
SUMOylation has previously been reported to be essential 
for proper chromosome segregation during mitosis (Tanaka 
et al., 1999; Biggins et al., 2001; Bachant et al., 2002; Azuma 
et al., 2003). We recently identified Claspin as a SUMOylated 
TOP2A-binding protein and demonstrated that inhibition of 
mitotic SUMOylation resulted in defective centromeric local-
ization of Claspin, which is known to bind to Chk1 (Kumagai 
and Dunphy, 2000; Ryu et al., 2015). Because Chk1 can acti-
vate Aurora B, our finding led us to investigate whether Aurora 
B was affected by the SUMOylation occurring on the mitotic 
chromosomes (Petsalaki et al., 2011). We inhibited mitotic 
SUMOylation specifically through the addition of dominant- 
negative mutant E2 enzyme Ubc9 (dnUbc9) in XEEs after the 
completion of DNA replication and before the onset of mitotic 
induction (Fig. 1 A). Immunoblotting analysis of Aurora B on 
replicated mitotic chromosomes indicated that the inhibition 
of mitotic SUMOylation reduced levels of both Aurora B and 
autophosphorylated Aurora B T248 (T232 in humans) on the 
mitotic chromosomes (Fig. 1 B). Aurora B levels were reduced 
by 20%, whereas phosphorylated and activated Aurora B levels 
were reduced by 35% on the mitotic chromosomes with the ad-
dition of dnUbc9 (Fig. 1 C). Furthermore, immunofluorescence 
staining of the mitotic chromosomes showed that the inhibi-
tion of SUMOylation reduced Aurora B localization at the 
centromeres (Fig.  1  D). Consistent with the immunoblotting 
results, the immunofluorescence signal intensity of Aurora B 
at the centromere was significantly reduced, by 34% (Fig. 1 E). 
These results suggest that mitotic SUMOylation could regulate 
centromeric Aurora B localization as well as the amount of ac-
tivated Aurora B on the mitotic chromosomes.
SUMOylated DNA topoisomerase IIα 
interacts with Haspin through Haspin SIMs
Although SUMOylation-dependent centromeric localization of 
Claspin could regulate the activation of Aurora B (represented 
by autophosphorylated T248) via Chk1, that may not explain 
the reduced binding of Aurora B through the inhibition of 
SUMOylation on X. laevis mitotic chromosomes because loss 
of Chk1 activity did not alter Aurora B localization in human 
cells (Petsalaki et al., 2011). Therefore, mitotic SUMOylation 
may regulate an additional mechanism for the robust binding 
of Aurora B to mitotic centromeres. To determine a connec-
tion between SUMOylated TOP2A and Aurora B, we looked 
to identify SUMOylated TOP2A CTD-binding proteins. For 
the comprehensive identification of SUMOylated TOP2A 
CTD-binding proteins, recombinant X.  laevis TOP2A CTD 
modified with SUMO2 by in vitro SUMOylation assay was 
prepared, as previously reported, to be used to pull down pro-
teins from XEEs through pull-down assays (Ryu et al., 2015). 
Pulled-down proteins on the beads were eluted with urea after 
being digested by SUMO protease SENP2 (Fig. 2 A). SENP2 
cleaves the conjugated SUMO2 protein from the modified 
TOP2A CTD, which allows for the pulled-down proteins to 
dissociate from the TOP2A CTD-bound beads and eliminates 
the high-molecular-weight contaminants of SUMOylated CTD 
bands in the samples. Urea-eluted proteins from both non- 
SUMOylated TOP2A CTD and TOP2A CTD SUMOylated 
with SUMO2 (CTD-SUMO) were subjected to LC-MS/MS 
analysis. LC-MS/MS identified multiple peptides of 61 pro-
teins that were pulled down with CTD-SUMO but not with the 
non-SUMOylated CTD (Table S1). Proteins identified included 
known SUMO-interacting proteins SET DB1 and RNF4 (Häkli 
et al., 2005; Rosendorff et al., 2006). Among the identified can-
didate proteins that were pulled down with CTD-SUMO and 
that could regulate Aurora B was histone H3 kinase Haspin. Im-
munoblotting analysis of the pull-down samples confirmed that 
Haspin bound specifically to the SUMOylated form of TOP2A 
CTD (Fig. 2 B). Therefore, Haspin was a potential target that 
could mediate Aurora B binding on the mitotic chromosomes 
in a SUMOylation-dependent manner. Haspin was previously 
reported to interact with Pds5, and the deletion of Pds5 could 
cause a reduction in H3T3 phosphorylation and the centromeric 
localization of Aurora B (Yamagishi et al., 2010; Carretero et al., 
2013). However, neither X. laevis Pds5a nor Pds5b was pulled 
down with either CTD or CTD-SUMO, suggesting that Pds5 is 
not involved in the protein interaction between SUMOylated 
TOP2A CTD and Haspin (Fig. S1).
Because a SUMO-interacting motif (SIM), a short se-
quence of large hydrophobic residues, can allow proteins to 
directly interact with SUMO on SUMOylated proteins (Song 
et al., 2004, 2005; Hecker et al., 2006; Ryu et al., 2015), we 
analyzed Haspin’s primary sequence using a SIM prediction 
program to determine whether Haspin possessed any SIMs 
(Xue et al., 2006). We identified two potential SIMs near the 
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N-terminal region of Haspin at aa 343–346 (VICL) and 364–367 
(VLCL; Fig. 2 C). To determine whether these sequences were 
important for Haspin’s interaction with SUMOylated TOP2A, 
we created a double SIM mutant (2-SIM) Haspin construct in 
pTGFC70 with a GFP-tag and a 3′ UTR of xKid (Ghenoiu et al., 
2013). Using mRNA created from the construct, we expressed 
either the wild-type (WT) Haspin-GFP or Haspin-GFP 2-SIM 
in XEEs separately at similar levels, and the Haspin-GFP– 
expressing XEEs arrested in metaphase with cytostatic factor 
(CSF XEEs) were subjected to pull-down assays with CTD-
SUMO (Fig.  2  D). Immunoblotting analysis showed that the 
expressed Haspin 2-SIM bound 48% less to CTD-SUMO than 
Haspin WT (Fig. 2 E). This indicates that the SIMs contribute 
to the robust binding of Haspin to SUMOylated TOP2A CTD. 
However, although mutations in the SIMs reduced the binding 
of Haspin to CTD-SUMO, they did not completely eliminate its 
binding capability, which suggests that another factor may be 
involved in the interaction.
Haspin localizes at mitotic centromeres for 
H3T3 phosphorylation in a SUMOylation-
dependent manner
Because TOP2A SUMOylation occurs primarily at the cen-
tromere during mitosis (Azuma et al., 2005; Ryu and Azuma, 
2010; Ryu et al., 2010b) and can regulate the centromeric local-
ization of Claspin as previously reported, we hypothesized that 
the localization of Haspin is dependent on the SUMOylation 
occurring on the mitotic chromosomes. To address this, we first 
examined whether mitotic SUMOylation in XEEs can regu-
late the binding of Haspin on the chromosomes. When SUMO 
Figure 1. Inhibition of SUMOylation reduces Aurora B ki-
nase on mitotic chromosomes. (A) Schematic method for the 
preparation of mitotic replicated chromosomes from XEEs. 
(B) Mitotic replicated chromosomes isolated as in A with 
(+dnUbc9) or without (control [Cont.]) dnUbc9 were sub-
jected to immunoblotting. Histone H3 was used for the load-
ing control for the mitotic chromosomes. (C) Quantification of 
Aurora B and Aurora B T248p levels on the mitotic chromo-
some, as seen in B, relative to levels of Cont. chromosomes 
from three independent experiments (n = 3) with levels nor-
malized to histone H3 levels. Error bars represent SD. *, P 
< 0.05 (Student’s t test). (D) Mitotic replicated chromosomes 
prepared as in A with or without dnUbc9 (Cont.) were sub-
jected to immunofluorescence staining with antibodies as indi-
cated with Hoechst 33342. Bar, 10 µm. (E) Quantification of 
the Aurora B signal intensity at mitotic centromeres, as seen in 
D, relative to signal intensities of Cont. centromeres from three 
independent experiments (n = 3, 50 centromeres per n) with 
levels normalized to CENP-A signal. Error bars represent SD. 
*, P < 0.05 (Student’s t test).
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modification was present on mitotic chromosomes, Haspin 
bound to mitotic chromosomes prominently (Fig. 3 A). How-
ever, inhibiting SUMOylation with the addition of dnUbc9 re-
duced the levels of Haspin bound on the mitotic chromosomes 
by 50% (Fig. 3 B). Also, H3T3p was reduced by 22% on the 
SUMOylation-inhibited mitotic chromosomes. These results 
suggest that the reduction in Haspin on the chromosomes with-
out SUMOylation occurring may reduce activity of Haspin on 
the chromosomes. Immunofluorescence staining of H3T3p on 
the mitotic chromosomes showed that inhibiting SUMOylation 
reduced its centromeric signal by 31% (Fig. 3, C and D; and 
Fig. S2). To determine whether the localization of Haspin 
on the mitotic chromosomes is affected by the inhibition of 
SUMOylation, we expressed Haspin-GFP in XEEs with the 
addition of Haspin-GFP mRNA. The colocalization of Haspin-
GFP with centromeric SUMO2/3 and CENP-A (Fig. 4 A) indi-
cated that Haspin localizes at the centromere to phosphorylate 
H3T3, as suggested by previous studies (Dai et al., 2005; Wang 
Figure 2. Haspin binding to TOP2A CTD is dependent on SUMOylation and SIMs. (A) Silver stain of the pulled-down proteins using TOP2A CTD. S-tagged 
non-SUMOylated (CTD) and SUMOylated CTD (CTD-SUMO) through in vitro SUMOylation assay were bound to S-agarose beads and incubated with CSF 
XEEs for pull-down assay. After incubation with SENP2 CD, proteins were eluted with urea and precipitated with trichloroacetic acid (TCA precip.). Lanes 1 
and 2 represent 5% of the S-tagged CTD and CTD-SUMO bound onto S-agarose beads as bait. Proteins in each fraction were visualized with silver stain. 
After elution, samples were the proteins remaining on S-agarose beads. Trichloroacetic acid–precipitated fractions were subjected to protein identification 
by LC-MS/MS. (B) SENP2-digested pull-down samples were analyzed by immunoblotting for Haspin. SENP2-digested S-tagged CTD was used as a loading 
control for the bait used in the pull-down assay. CSF lane represents 0.75% of the volume of XEEs used for each pull-down sample. CSF Haspin indicates 
the endogenous band found in the CSF XEEs, and Bound Haspin indicates the Haspin band in the pull-down sample. (C) Schematic representation of the 
primary structure of X. laevis Haspin. SIMs are located at aa 343–346 (VICL) and 364–367 (VLCL). Point mutations in each SIM are indicated in red for the 
disrupted SIM mutant protein (2-SIM). (D) mRNAs of GFP-tagged WT or 2-SIM Haspin were supplemented in XEEs to express Haspin-GFP, and Haspin-GFP–
expressing CSF XEEs were subjected to the pull-down assay with S-tagged CTD SUMOylated (CTD-SUMO) through in vitro SUMOylation assay and bound 
onto S-agarose beads (middle). After SENP2-CD incubation, CTD-SUMO–bound Haspin-GFP was analyzed by immunoblotting (right). SENP2-digested 
S-tagged CTD was used as a loading control for the bait used in the pull-down assay. CSF XEE lanes represent 0.5% of the volume of the Haspin-GFP– 
expressing CSF XEEs used for each pull-down sample. (E) Quantification of pulled-down Haspin-GFP levels by CTD-SUMO, as seen in D, relative to Haspin-
GFP WT levels from three independent experiments (n = 3) with levels normalized by CTD levels. Error bar represents SD. ***, P < 0.001 (Student’s t test).
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et al., 2010). However, the inhibition of SUMOylation caused a 
reduction of Haspin-GFP at mitotic centromeres, with signal in-
tensity 21% of that when SUMOylation was present (Fig. 4 B). 
From these results, we conclude that mitotic SUMOylation con-
tributes to the centromeric Haspin localization as well as the 
phosphorylation of centromeric H3T3. Interestingly, whereas 
exogenous Haspin-GFP expression also showed the localization 
of Haspin on the chromosomal arm regions, the inhibition of 
SUMOylation reduced those signals as well.
TOP2A C-terminal SUMOylation regulates 
Haspin binding and H3T3 phosphorylation 
on mitotic chromosomes
Although inhibition of mitotic SUMOylation reduced the bind-
ing of Haspin and H3T3p levels on the chromosomes, dnUbc9 
addition inhibited not only the SUMOylation of TOP2A in 
XEEs, but other proteins that are known to be SUMOylated 
at the mitotic centromeres as well (Ryu et al., 2010a; Sridha-
ran et al., 2015). To address whether SUMOylation of TOP2A 
CTD is responsible for the regulation of Haspin, we prepared 
mitotic chromosomes using recombinant TOP2A WT or 3KR 
(in which all three known SUMO acceptor lysines on the CTD 
were mutated to arginine; Ryu et al., 2015) by removing en-
dogenous TOP2A from the XEEs through immunodepletion 
while adding back the recombinant TOP2A (Fig. 5, A and B). 
Chromosomes were assembled in TOP2A-replaced CSF XEEs, 
and Haspin and H3T3p levels were analyzed on the chromo-
somes by immunoblotting. When endogenous TOP2A was re-
placed by recombinant TOP2A WT, endogenous Haspin and 
H3T3p on the mitotic chromosomes were reduced by 39% and 
36%, respectively, in the presence of dnUbc9 (Fig. 5, B and C). 
However, mitotic chromosomes from TOP2A 3KR–replaced 
XEEs also showed reduction of both Haspin and H3T3p, with 
levels reduced by 68% and 36%, respectively. Chromosomes 
with TOP2A 3KR with dnUbc9 present showed slightly fur-
ther reduction, with Haspin levels reduced by 76% and H3T3p 
levels reduced by 56%, but the difference was not statistically 
significant compared with levels without dnUbc9. These re-
sults suggest that SUMOylation of TOP2A CTD substantially 
contributes to binding of Haspin on mitotic chromosomes and 
that the binding of Haspin is critical for the prominent phos-
phorylation of H3T3. Interestingly, the TOP2A 3KR–replaced 
XEEs with the addition of dnUbc9 revealed further reduction of 
both Haspin and H3T3p, which suggests that dnUbc9 addition 
may affect an additional recruitment mechanism of Haspin on 
the chromosomes other than through the SUMOylation of the 
C-terminal region of TOP2A.
Mitosis-specific phosphorylation of Haspin 
T206 regulates binding to SUMOylated  
TOP2A CTD
Although mutating the two SIMs reduced Haspin 2-SIM levels 
bound to SUMOylated TOP2A CTD through pull-down assays, 
it did not completely eliminate the interaction (Fig. 2, D and E). 
This result suggests that whereas the SUMOylation of TOP2A 
CTD is essential for the binding of Haspin, another factor con-
tributes to the robust binding between SUMOylated TOP2A 
and Haspin. Interestingly, the molecular weight of Haspin-GFP 
Figure 3. SUMOylation on mitotic chromo-
somes regulates Haspin binding and H3T3 
phosphorylation. (A) Mitotic replicated chro-
mosomes prepared as in Fig. 1 A with (Cont.) 
or without (+dnUbc9) mitotic SUMOylation. 
Isolated chromosomes were analyzed by 
immunoblotting with indicated antibodies. 
Histone H3 was used as a loading control 
for the mitotic replicated chromosomes. (B) 
Quantification of Haspin and H3T3p levels 
on the mitotic replicated chromosomes, as 
seen in A, relative to levels of Cont. chromo-
somes from three independent experiments 
(n = 3) with levels normalized to histone H3 
levels. Error bar represents SD. *, P < 0.05 
(Student’s t test). (C) Mitotic replicated chromo-
somes prepared from CSF XEEs with (Cont.) or 
without (+dnUbc9) mitotic SUMOylation were 
subjected to immunofluorescence staining with 
antibodies as indicated with Hoechst 33342. 
(D) Quantification of H3T3p signal intensity at 
the mitotic centromeres, as seen in C, relative 
to signal intensities of Cont. centromeres from 
three independent experiments (n = 3, 40 
centromeres per n) with levels normalized to 
CENP-A.  Error bar represents SD. ***, P < 
0.001 (Student’s t test).
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was increased in the pull-down sample compared with Haspin-
GFP expressed in XEEs. The molecular weight shift suggests 
that a posttranslational modified form of Haspin bound onto the 
SUMOylated CTD. Haspin has been reported to be phosphor-
ylated specifically during mitosis at multiple sites by kinases 
such as Cdk1 and Plk1 to activate Haspin (Wang et al., 2011; 
Ghenoiu et al., 2013; Zhou et al., 2014). To determine whether 
the cell cycle–specific phosphorylation of Haspin contributes 
to the interaction of Haspin with SUMOylated TOP2A, we 
performed pull-down assays using either mitotic CSF XEEs or 
interphase XEEs expressing Haspin-GFP at similar levels, be-
cause of difficulty in detecting endogenous Haspin in XEEs and 
to eliminate the possibility of different Haspin expression levels 
between mitotic CSF XEEs and interphase XEEs. As a previ-
ous study reported (Ghenoiu et al., 2013), exogenous Haspin 
in mitotic CSF XEEs showed a larger molecular weight than 
Haspin in interphase XEEs because of mitotic phosphorylation 
(Fig.  6 A). Haspin-GFP was not detected in the pulled-down 
fractions from non-SUMOylated TOP2A CTD in CSF or in-
terphase XEEs. However, when CTD-SUMO was used to pull 
down Haspin, the interphase form of Haspin-GFP was 73% less 
abundant compared with mitotic CSF Haspin-GFP (Fig. 6 B). 
This result suggests that, because mitotic Haspin bound much 
more abundantly to SUMOylated CTD than the interphase form 
of Haspin, the cell cycle–specific phosphorylation of Haspin can 
regulate its stable interaction with SUMOylated TOP2A. The 
initial phosphorylation for Haspin kinase activation is mediated 
by Cdk1 at threonine 206 in X. laevis and threonine 128 in Homo 
sapiens (Ghenoiu et al., 2013; Zhou et al., 2014). T206 acts as a 
priming site that, when phosphorylated by Cdk1, promotes Plk1 
binding for subsequent phosphorylation, which leads to Haspin 
activation. Because the mitotic phosphorylation of Haspin may 
play a critical role in its interaction with SUMOylated TOP2A, 
we examined how a T206A mutation affected Haspin binding 
to CTD-SUMO (Fig.  6 C). Haspin-GFP WT, T206A, 2-SIM, 
and a combined T206A/2-SIM mutant were expressed in XEEs 
separately at similar levels with Haspin-GFP mRNA addition 
(Fig. 6 D). CTD-SUMO pulled down Haspin 2-SIM at 57% of 
WT, similar to what was observed in Fig. 2 E, whereas Haspin 
T206A was pulled down less, at 15% of WT levels (Fig. 6 E). 
The combined T206A/2-SIM mutant showed slightly lower lev-
els pulled down, at 9% of WT. These results suggest that phos-
phorylation of T206 greatly contributes to the stable interaction 
between Haspin and SUMOylated TOP2A, more so than the 
SIMs, in the in vitro pull-down assays.
Haspin T206 and SIMs regulate its 
centromeric localization on mitotic 
chromosomes
Because both T206A and SIM mutations reduced the binding of 
Haspin to SUMOylated TOP2A CTD, we looked to determine 
whether these mutations also affected the centromeric local-
ization of Haspin through immunofluorescence using Haspin-
GFP WT, T206A, 2-SIM, and T206A/2-SIM expression with 
the addition of mRNA. To be sure that all four proteins were 
expressed at similar levels, different mRNA concentrations for 
Figure 4. SUMOylation regulates centro-
meric Haspin localization during mitosis. (A) 
Haspin-GFP mRNA was supplemented in 
XEEs for protein expression (top), and mitotic 
replicated chromosomes prepared without or 
with dnUbc9 were subjected to immunofluo-
rescence staining with indicated antibodies 
with Hoechst 33342. β-Tubulin was used as 
a loading control for Haspin-GFP expression 
levels in XEEs. Bar, 10 µm. (B) Quantification 
of centromeric Haspin-GFP signal intensity, 
as seen in A, relative to signal intensities of 
+Haspin-GFP centromeres from three indepen-
dent experiments (n = 3, 50 centromeres per 
n) with levels normalized to CENP-A. Error bar 
represents SD. **, P < 0.01 (Student’s t test).
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each Haspin-GFP form were added into XEEs, and the chromo-
somes from XEEs with similar expression levels of Haspin-GFP 
(Fig. 7 A, lanes 2, 5, 8, and 11) were compared. Analysis of the 
centromeric Haspin-GFP signals showed a clear reduction in 
the centromeric Haspin localization with the mutant forms. Rel-
ative to WT Haspin-GFP levels, Haspin-GFP levels at the cen-
tromeres were reduced to 44% in the T206A mutant and 46% 
in the 2-SIM mutant (Fig. 7 B). Combining the mutations for 
the T206A/2-SIM mutant reduced the Haspin-GFP signal inten-
sity more at the centromeres, to 23%. This result suggests that 
T206 phosphorylation and the SIMs contribute to the binding of 
Haspin to SUMOylated TOP2A CTD through an additive effect.
Altogether, our results suggest that the mitotic chro-
mosomal binding of Haspin at the centromeres can be reg-
ulated by its interaction with TOP2A. This interaction 
occurs at the C-terminal region of TOP2A and is mediated 
by SUMOylation on TOP2A, Haspin SIMs, and the mitotic 
phosphorylation on Haspin.
Discussion
Because Aurora B acts as a key mitotic regulator at the centromere 
during early mitosis, regulation of the recruitment of the CPC is 
essential for proper mitotic progression. Haspin has been reported 
to contribute to CPC recruitment (Kelly et al., 2010; Wang et al., 
2010). However, the mechanism for the localization of Haspin 
remained unclear in vertebrates. Our results imply a novel inter-
action between TOP2A and Haspin for the centromeric Haspin 
localization that is mediated by two different modifications: (a) 
the phosphorylation of Haspin required for kinase activation and 
(b) the SUMOylation of TOP2A C-terminal region (Fig. 8). When 
both TOP2A and Haspin have been modified, active Haspin is re-
cruited by SUMOylated TOP2A and binds to the vicinity of cen-
tromeric histone H3 to phosphorylate H3T3. H3T3p then allows 
for CPC to localize at the centromeres, whereas Bub1-mediated 
phosphorylation of H2A T120 also contributes in the recruitment 
of the CPC via Shugoshin proteins (Kawashima et al., 2010; 
Yamagishi et al., 2010). However, mutating Haspin T206 is sug-
gested to eliminate both Cdk1- and Plk1-dependent phosphor-
ylation (Ghenoiu et al., 2013). Therefore, it remains unknown 
whether the phosphorylation of T206 mediated by Cdk1 or the 
phosphorylation of the sites mediated by Plk1 on Haspin is im-
portant for its interaction with TOP2A. It also remains unclear 
how phosphorylated T206 and potentially other phosphorylated 
sites on Haspin contribute structurally to the interaction with SU-
MOylated TOP2A. Without SUMOylation, TOP2A and Haspin 
do not bind, which suggests that SUMOylation is essential for 
the two proteins to interact. However, even without the SIM se-
quences, Haspin can bind to SUMOylated TOP2A, though not 
Figure 5. SUMOylation of TOP2A CTD regulates Haspin 
binding and H3T3 phosphorylation on mitotic chromosomes. 
(A) Schematic representation of the primary structure of 
X.  laevis TOP2A. Three lysines indicated in the CTD were 
mutated to arginine for a TOP2A mutant that could not be 
SUMOylated in the CTD (3KR). (B) Endogenous TOP2A in 
CSF XEEs was immunodepleted and replaced with either re-
combinant full-length T7-TOP2A WT or 3KR (left). β-Tubulin 
was used as a loading control of TOP2A levels in CSF 
XEEs. Mitotic chromosomes assembled in TOP2A-replaced 
CSF XEEs were analyzed by immunoblotting with indicated 
antibodies (right). Histone H4 was used as a loading con-
trol for mitotic chromosomes. (C) Quantification of Haspin 
and H3T3p levels on the mitotic chromosomes, as seen in 
B, relative to levels of TOP2A WT chromosomes from three 
independent experiments (n = 3) with levels normalized to 
histone H4 levels. Error bar represents SD. *, P < 0.05; **, P 
< 0.01 (Student’s t test).
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Figure 6. Cell cycle–dependent Haspin T206 phosphorylation regulates SUMOylated TOP2A CTD–Haspin interaction. (A) Either CSF XEEs or interphase 
XEEs (Int.) expressing Haspin-GFP (left) were used in pull-down assays with S-tagged non-SUMOylated (CTD) and SUMOylated CTD (CTD-SUMO) bound 
to S-agarose beads (middle), and Haspin-GFP binding was analyzed by immunoblotting (right). β-Tubulin was used as a loading control for Haspin-GFP 
levels in XEEs (loading 0.5% of the volume of XEEs used in each pull-down sample). SENP2-digested S-tagged CTD was used as the loading control for the 
bait used in the pull-down assay. (B) Quantification of pulled-down Haspin-GFP levels with CTD and CTD-SUMO, as seen in A, relative to levels from the 
pull-down sample using CSF XEEs with CTD-SUMO from three independent experiments (n = 3) with levels normalized to TOP2A CTD levels. Error bar rep-
resents SD. **, P < 0.01 (Student’s t test). (C) Schematic representation of X. laevis Haspin mutants. Threonine 206 (T206) was mutated to alanine (T206A) 
to eliminate the mitotic phosphorylation site. T206A/2-SIM indicates the combined T206A and the double SIM mutations. (D) Expressed WT, T206A, 
2-SIM, and T206A/2-SIM Haspin-GFP in CSF XEEs (top) were used in pull-down assays with S-tagged CTD and CTD-SUMO bound onto S-agarose beads 
with Haspin-GFP binding analyzed by immunoblotting (bottom). β-Tubulin was used as a loading control for Haspin-GFP levels in XEEs (loading 0.5% of the 
volume of XEEs used in each pull-down sample; top). SENP2-digested S-tagged CTD was used as the loading control for the bait used in the pull-down assay 
(bottom). (E) Quantification of pulled-down Haspin-GFP levels with CTD and CTD-SUMO, as seen in D, relative to Haspin-GFP WT levels of CTD-SUMO from 
three independent experiments (n = 3) with levels normalized to TOP2A CTD levels. Error bar represents SD. *, P < 0.05; **, P < 0.01 (Student’s t test).
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robustly. This could be because (a) SUMOylation of TOP2A can 
cause structural change in the CTD, which exposes a surface for 
phosphorylated Haspin to interact with; (b) phosphorylation of 
Haspin creates phospho-regulated SIMs (Stehmeier and Muller, 
2009) that interact directly with the SUMO protein more tightly; 
or (c) the phosphorylation-dependent Haspin conformational 
changes suggested by Ghenoiu et al. (2013) allow it to bind to 
SUMOylated TOP2A. Future studies involving Haspin phos-
phorylation site mutants may provide insight on the specific sites 
that mediate this protein interaction.
Although our results show that the TOP2A CTD 
SUMOylation can regulate the binding of Haspin on the mitotic 
chromosomes by using TOP2A 3KR mutant, the addition of 
dnUbc9 to the XEEs with TOP2A 3KR mutant showed a greater 
reduction in both Haspin and H3T3p levels on mitotic chromo-
somes than without the presence of dnUbc9, even though the dif-
ference was not statistically significant. This result suggests that 
although TOP2A SUMOylation can regulate Haspin binding, 
other SUMOylated proteins on the mitotic chromosomes may 
function to allow for the binding of Haspin and, thus, also affect 
H3T3p levels on the chromosomes. It may also be possible that 
the SUMOylation of TOP2A K660 that we have previously re-
ported contributes to the binding of Haspin on the mitotic chro-
mosomes (Ryu et al., 2010b). Additionally, Haspin binding on 
the mitotic chromosomes and the centromeric Haspin localiza-
tion were not completely eliminated when SUMOylation was in-
hibited or when both T206 and the SIMs were mutated together. 
This result indicates that there could be other mechanisms 
Figure 7. Haspin SIMs and the phosphory-
lation of Haspin contribute to its localization 
at mitotic centromeres. (A) Mitotic replicated 
chromosomes prepared from Haspin-GFP–
expressing XEEs with different mRNA con-
centrations of Haspin WT, T206A, 2-SIM, or 
T206A/2SIM mutant were subjected to immu-
nofluorescence staining. Immunofluorescence 
staining of chromosomes from XEEs with sim-
ilar levels of expressed Haspin-GFP is shown 
and compared (lane 2, WT; lane 5, T206A; 
lane 8, 2-SIM; and lane 11, T206A/2-SIM). 
β-Tubulin was used as a loading control for 
Haspin-GFP levels in CSF XEEs (top). Bars, 
10 µm. (B) Chromosomes from XEEs with simi-
lar levels of expressed Haspin-GFP were quan-
tified using centromeric Haspin-GFP signal 
intensity, as seen in A, relative to signal inten-
sities of Haspin-GFP WT from three indepen-
dent experiments (n = 3, 30 centromeres per 
n) with levels normalized to SUMO2/3. Error 
bar represents SD. *, P < 0.05; **, P < 
0.01 (Student’s t test).
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for Haspin binding on the mitotic chromosomes that are inde-
pendent of SUMOylation, such as through the interaction with 
the cohesin cofactor Pds5 (Yamagishi et al., 2010).
An analysis in budding yeast, concurrently reported with 
this study, shows that H3T3p-mediated Aurora B (Ipl1 in budding 
yeast) localization at the mitotic centromeres is conserved, and 
mislocalization of Aurora B is observed in yeast with a truncated 
form of TOP2 lacking the CTD (unpublished data). Rescue of the 
H3T3p-dependent Aurora B localization in the truncated TOP2 
mutant yeast by H3T3E substitution supports the conserved role 
of the CTD in the regulation of Aurora B localization in eukary-
otes. Previous study has shown that TOP2A contributes in the 
regulation of Aurora B activity at the centromeres in somatic 
cells with TOP2 inhibitor treatment (Coelho et al., 2008). TOP2 
inhibitors have also been known to increase the SUMOylation 
of TOP2A in mitotic HeLa cells (Agostinho et al., 2008). Our 
results suggest that the SUMOylation-dependent regulation of 
Haspin may explain the molecular mechanism of the TOP2 in-
hibitor–dependent regulation of Aurora B. In addition, a recent 
study indicated that specific mutations of TOP2 in budding yeast 
that obstruct the strand-passaging enzymatic reaction of TOP2 
at different enzymatic steps can induce mitotic checkpoint acti-
vation (Furniss et al., 2013). This mitotic checkpoint activation 
required the C-terminal region of TOP2, suggesting that TOP2 
CTD can provide a signal to the mitotic checkpoint machinery. 
An intriguing question for the future is whether the SUMOylated 
TOP2A CTD and Haspin interaction is involved in the checkpoint 
activation caused by the strand-passaging reaction mutant TOP2.
Materials and methods
DNA constructs, site-directed mutagenesis, recombinant protein 
expression, and antibodies
For recombinant full-length X.  laevis TOP2A proteins, cDNAs were 
subcloned into a pPIC3.5 vector (Thermo Fisher Scientific) that had 
a calmodulin-binding protein (CBP)–T7 tag sequence and were ex-
pressed in the GS115 strain of Pichia pastoris yeast. CBP-T7 tagged 
TOP2A proteins were extracted by grinding frozen yeast cells with 
dry ice, followed by the addition of lysis buffer (150  mM NaCl, 
2 mM CaCl2, 1 mM MgCl2, and 30 mM Hepes, pH 7.8), and purified 
by calmodulin-agarose (GE Healthcare) affinity chromatography and 
by anion exchange column (GE Healthcare) as previously described 
(Ryu et al., 2010a,b). TOP2A CTD (aa 1,222–1,579) was subcloned 
into pET30a (EMD Millipore) and SENP2 catalytic domain (CD; 
aa 363–589), and PIASy cDNAs were subcloned into pET28a vectors 
(EMD Millipore) with an N-terminal His tag. For E1 complex (Aos1/
Uba2 heterodimer), Uba2 and Aos1 cDNAs were subcloned into pRSF 
Duet vector (EMD Millipore) and expressed together in Escherichia 
coli. Both WT and dominant-negative forms of Ubc9 (dnUbc9-C93S/
L97S) were subcloned into pT7-7 vectors (from M. Dasso, National 
Institutes of Health, Bethesda, MD; Tabor and Richardson, 1985), and 
SUMO2-GG was subcloned into pGEX4T-1 (GE Healthcare) with an 
N-terminal GST tag. All proteins were expressed in BL21 (DE3) or 
Rosetta 2 (DE3) bacteria at either 15°C in 2× YT medium containing 
5% glycerol and 2.5% ethanol (for TOP2A CTD, SENP2 catalytic do-
main, PIASy, and E1 complex) or 30°C in 2× YT medium (for Ubc9 
and SUMO2-GG). Proteins with His-6 tag (TOP2A CTD, PIASy, and 
Figure 8. Model for centromeric Haspin recruitment by DNA 
topoisomerase IIα. (1) Centromeric DNA topoisomerase IIα 
is SUMOylated (S) at the C-terminal domain by SUMO E3 
ligase PIASy, whereas Haspin is phosphorylated (P) by Cdk1 
at T206 during the onset of mitosis. Plk1 binds to phosphor-
ylated T206 to phosphorylate other sites on Haspin to cre-
ate active Haspin kinase. (2) SUMOylated topoisomerase 
IIα recruits active Haspin to the centromere to allow for the 
phosphorylation of histone H3 (purple) at threonine 3 (T3). 
Phosphorylated T3 recruits CPC members to the centromere 
through direct interaction with Survivin. H2A (dark purple) 
T120 phosphorylation mediated by Bub1 additionally 
contributes to the recruitment of CPC members to the cen-
tromere through the binding of Shugoshin 1/2 (Sgo1/2) that 
interacts with Borealin.
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SENP2 CD) were extracted by lysing cells in buffer (500 mM NaCl, 
1  mM MgCl2, 25  mM Hepes, pH 7.8, 5% glycerol, 1  mM PMSF, 
and 0.5% Triton X-100) with 0.1 mg/ml lysozyme (Sigma-Aldrich). 
His-6–tagged proteins were purified using Cobalt affinity beads (Talon 
Beads; Takara Bio Inc.) from soluble fractions after centrifugation at 
25,000 g for 40 min. Proteins were eluted with imidazole, and imid-
azole-eluted fractions were further separated by ion-exchange col-
umns. For E1 complex purification, cells were lysed as noted earlier 
except with 150  mM NaCl concentration. The E1 complex–contain-
ing imidazole elutions were loaded onto a SUMO1 affinity column 
(GST-SUMO1-GG conjugated to NHS-Sepharose; GE Healthcare) in 
the presence of ATP, and bound E1 complex was eluted by DTT elution 
buffer (100 mM NaCl, 1 mM MgCl2, 30 mM Tris, pH 8.8, 5% glyc-
erol, and 10 mM DTT). E1 complex–containing DTT-eluted fractions 
were further purified by anion exchange column. GST-SUMO2-GG 
was extracted from E.  coli cells by the lysis method mentioned ear-
lier and captured on glutathione-Sepharose beads (GE Healthcare). 
Bound beads were incubated with thrombin to cleave the GST tag to 
elute untagged SUMO2-GG. Eluted SUMO2-GG was further purified 
by anion exchange column followed by Sephacryl S-100 gel filtration 
(GE Healthcare). Ubc9 proteins were extracted by sonication in 50 mM 
NaCl lysis buffer. The soluble fraction after centrifugation was loaded 
onto the anion exchange column. Collected Ubc9 proteins were sep-
arated by cation exchange column followed by Sephacryl S-100 gel 
filtration. All proteins were concentrated with buffer exchanged to 
100 mM NaCl, 1 mM MgCl2, 20 mM Hepes, pH 7.8, 5% glycerol, and 
0.5 mM tris(2-carboxyethyl)phosphine with a centrifugal concentrator 
(Amicon Ultra; Thermo Fisher Scientific). The protein concentrations 
were measured using the Bradford method (Bio-Rad Laboratories), 
with BSA as the standard. Purified proteins were snap-frozen with liq-
uid nitrogen and stored at −80°C.
X.  laevis Haspin cloned into a pTGFC70 plasmid with a C- 
terminal GFP tag and a 3′-UTR sequence of xKid was a gift from H.  
Funabiki (Rockefeller University, New York, NY). SIMs were predicted 
using the GPS-SUMO prediction program (Xue et al., 2006). Mutations 
in the SIMs at aa 343–346 (VICL to AICA) and aa 364–367 (VLCL to 
ALCA) and the T206A (threonine to alanine) mutation were generated 
by site-directed mutagenesis using a QuikChange II XL kit (Agilent 
Technologies) according to the manufacturer’s protocol and verified by 
DNA sequencing. WT and mutant Haspin mRNA were obtained by 
in vitro transcription reaction with mMES SAGE mMAC HINE SP6 kit 
(Thermo Fisher Scientific) from pTGFC70 plasmid as previously de-
scribed (Kelly et al., 2010; Ghenoiu et al., 2013). The pTGFC70 plas-
mids of WT and mutant Haspin-GFP were first linearized with NotI 
restriction enzyme digestion. Linearized pTGFC70 plasmids were in-
cubated with the mMES SAGE mMAC HINE SP6 kit transcription mix-
ture for 3 h at 37°C to synthesize mRNA. The transcribed mRNAs were 
precipitated in LiCl for recovery and dissolved in nuclease-free H2O.
Antibodies used for the study are as follows. For immunoblotting, 
rabbit anti-SUMO2/3 polyclonal antibody (1:1,000) and rabbit poly-
clonal antibody against the TOP2A C-terminus region (aa 1,358–1,579; 
1:1,000) were prepared as previously described (Azuma et al., 2003; 
Ryu and Azuma, 2010; Ryu et al., 2010b). Anti–Aurora B kinase rabbit 
polyclonal antibody (1:1,000) was prepared with full-length X. laevis 
Aurora B as the antigen. Rabbit anti-Haspin polyclonal antibody for 
X.  laevis was a gift of H. Funabiki (Kelly et al., 2010). Rabbit poly-
clonal antibodies of anti-Pds5a and anti-Pds5b for X. laevis were a gift 
of T. Hirano (Institute of Physical and Chemical Research, Saitama, 
Japan; Losada et al., 2005). Commercial antibodies used for immu-
noblotting analysis were mouse monoclonal anti-GFP (JL-8, 1:1,000; 
Takara Bio Inc.), rabbit monoclonal anti–Aurora B kinase T232 phos-
phorylation (T248 in X.  laevis, 1:1,000; Cell Signaling Technology), 
rabbit polyclonal anti–histone H3 (1:1,000; Cell Signaling Technol-
ogy), rabbit polyclonal anti–histone H4 (1:1,000; Abcam), rabbit poly-
clonal anti-H3T3p (1:1,000; Abcam), S-protein-HRP (1:2,000; EMD 
Millipore), and mouse monoclonal anti–β-tubulin (1:1,000; Sigma- 
Aldrich). For immunofluorescence staining, anti-SUMO2/3 guinea 
pig polyclonal antibody (1:500) and chicken polyclonal anti–X. laevis 
CENP-A (1:500) were prepared as previously described (Azuma et al., 
2003; Ryu et al., 2010a,b; Ryu and Azuma, 2010), and anti–Aurora B 
rabbit polyclonal antibody (1:500) was used. Commercial antibodies 
used for immunofluorescence analysis were mouse anti–topoisomer-
ase II monoclonal antibody (1:1,000; MBL International) and rabbit 
polyclonal anti–histone H3T3p (1:25,000; Abcam). Primary antibodies 
were visualized by fluorescence-labeled secondary antibodies (Thermo 
Fisher Scientific): goat anti–mouse IgG Alexa Fluor 488 (1:500), goat 
anti–rabbit IgG Alexa Fluor 568 (1:500), goat anti–guinea pig IgG Alexa 
Fluor 678 (1:500), and goat anti–chicken IgG Alexa Fluor 488 (1:500).
XEEs, immunodepletion/add-back assay, and pull-down assays
Low-speed extracts of X. laevis eggs arrested in metaphase with cyto-
static factor (CSF XEEs) and demembraned sperm nuclei were prepared 
according to standard protocols (Murray, 1991; Kornbluth and Evans, 
2001). Immunodepletions of endogenous TOP2A were performed 
with protein A–conjugated magnetic beads (Thermo Fisher Scientific; 
Arnaoutov and Dasso, 2003). Equal volumes of rabbit anti-TOP2A 
antibody (1 mg/ml) and protein A Dynabeads suspension were incu-
bated to capture the antibodies on Dynabeads. Anti-TOP2A–captured 
beads were blocked with 5% BSA containing CSF-XB (100 mM KCl, 
0.1  mM CaCl2, 2  mM MgCl2, 5  mM EGTA, 50  mM sucrose, and 
10 mM Hepes, pH 7.8). To reach greater than 99% depletion of TOP2A 
from XEEs, we used anti-TOP2A–captured Dynabeads from initial 
Dynabead suspension at a ratio of 1.1 µl suspension to 1 µl XEEs (i.e., 
440 µl suspension of anti-TOP2A Dynabeads were used for immuno-
depletion in 400 µl XEEs in Fig. 5). The XEE/Dynabeads mixture was 
incubated for 15 min at RT followed by 15-min incubation on ice. For 
add-back experiments, purified recombinant T7-TOP2A proteins were 
added to immunodepleted extracts at levels similar to the endogenous 
TOP2A, which was confirmed by immunoblotting. Chromosome isola-
tions were performed as previously reported (Azuma, 2009). For chro-
mosome isolation, interphase extract was first obtained by releasing 
metaphase-arrested XEEs with 0.6 mM CaCl2. Demembranated sperm 
nuclei were incubated in interphase XEEs at 6,000 sperm nuclei/µl, and 
an equal volume of CSF XEEs was added to induce the onset of mito-
sis. Mitotic SUMOylation was inhibited by the addition of 150 ng/µl 
dnUbc9 to the interphase XEEs as well as the CSF XEEs right before 
the two XEEs were combined for the induction of mitosis from inter-
phase. After incubation, XEEs were diluted by three times their volume 
with 0.5× CSF-XB supplemented with 18  mM β-glycerophosphate, 
0.25% Triton X-100, 10 mg/ml protease inhibitors (leupeptin, pepsta-
tin, and chymostatin; EMD Millipore), and 0.2 µM okadaic acid (EMD 
Millipore). Diluted XEEs were layered onto dilution buffer containing 
35% glycerol and centrifuged at 10,000 g for 5 min at 4°C. Precipi-
tated chromosomes were boiled in SDS-PAGE sample buffer, and the 
extracted proteins were subjected to immunoblotting with antibodies. 
Immunoblotting signals were acquired with Image Station 4000R (Car-
estream Health), and the signal levels were quantified by ImageJ soft-
ware. Relative levels were calculated by measuring the signal levels of 
each protein band, normalizing values to the loading controls indicated 
in each figure, and taking the mean and SD of three independent ex-
periments for each assay. Statistical significance of the difference was 
calculated by t test of the means.
The XEE pull-down assays were performed as described pre-
viously with 10  mM iodoacetamide addition in buffers to prevent 
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deSUMOylation activity in the XEEs (Ryu and Azuma, 2010). XEEs 
were diluted by two times their volume with PD buffer (20 mM so-
dium phosphate, pH 7.8, 18 mM β-glycerol phosphate, pH 7.5, 5 mM 
MgCl2, 50 mM NaCl, 5% glycerol, 1 mM DTT, and 10 mM iodoac-
etamide), and diluted XEEs were centrifuged at 25,000 g for 45 min 
at 4°C.  An equal volume of the PD buffer supplemented with 0.2% 
Tween 20 and 0.2% Triton X-100 was added to the supernatants and 
incubated with S-tagged TOP2A CTD-bound or SUMOylated TOP2A 
CTD-bound S-agarose beads for 1 h at RT. After washing with PD buf-
fer, the beads were incubated in the dilution buffer (20  mM sodium 
phosphate, pH 7.8, 18 mM β-glycerol phosphate, pH 7.5, 5 mM MgCl2, 
50 mM NaCl, and 5% glycerol) containing 35 µg/ml SENP2-CD for 
45 min at RT to cleave conjugated SUMO2 from TOP2A CTD and 
dissociate pulled-down proteins from the beads. SDS-PAGE samples 
were prepared by adding a half volume of 3× SDS-PAGE sample buffer 
to the bead suspension. All samples were separated on 8–16% Tris- 
glycine gels (Thermo Fisher Scientific) by SDS-PAGE and analyzed 
with silver staining or immunoblotting. For the preparation of samples 
for LC/MS-MS analysis, pull-down samples and the soluble fractions 
were isolated using spin columns, washed with urea, and precipitated 
with trichloroacetic acid. Samples were subjected to LC/MS-MS analy-
sis for protein identification (performed by S.P. Gygi, Harvard Medical 
School, Boston, MA). In the case of pull-down assays with Haspin-
GFP–expressing XEEs, interphase XEEs with 10 ng/µl Haspin-GFP 
mRNA were incubated for 150 min at RT and then returned to mitotic 
phase by adding an equal volume of CSF XEEs or kept in interphase 
XEEs for the pull-down experiment in Fig.  6  A.  Protein expression 
levels in XEEs after incubation with mRNA were checked through 
immunoblotting and adjusted accordingly with additional volumes of 
the original CSF XEEs or interphase XEEs to achieve similar protein 
expression concentrations before being used for pull-down assays. Im-
munoblotting signals were acquired by Image Station 4000R (Care-
stream Health), and signal levels were quantified by ImageJ software. 
Relative levels were calculated by measuring the signal levels of each 
protein band, normalizing the values to the recombinant TOP2A CTD 
levels, and taking the mean and SD of three independent experiments 
for each assay. Statistical significance of the difference was calculated 
by t test of the means.
Immunofluorescence analysis of chromosomes
The mitotic chromosomes used for the immunofluorescence analysis 
were prepared as previously described (Azuma et al., 2005). Replicated 
mitotic chromosomes were prepared by incubating demembranated 
sperm chromatin at 1,000 sperm nuclei/µl in interphase XEEs by adding 
0.6 mM CaCl2, followed by the induction of mitosis with the addition 
of an equal volume of CSF XEEs. To inhibit SUMOylation, 150 ng/µl 
dnUbc9 was added to both the interphase XEEs and CSF XEEs before 
they were combined to induce the onset of mitosis. XEE-containing 
mitotic chromosomes were diluted by three times their volume with 
IF-dilution buffer (0.5× CSF-XB containing 18  mM β-glycerophos-
phate and 250  mM sucrose) and an equal volume of fixation buffer 
(IF-dilution buffer with 4% p-formaldehyde) followed by incubation 
for 10 min at RT. Fixed samples were layered on top of 8 ml of 40% 
glycerol cushion in glass tubes with coverslips. The chromosomes 
were spun down onto the coverslips by centrifuging at 6,000 g for 20 
min at RT. Chromosomes on the coverslips were postfixed with 1.6% 
p-formaldehyde in PBS for 5 min at RT. The specimens were blocked 
with PBS containing 5% BSA and 2.5% cold-fish gelatin and subjected 
to immunostaining with the antibodies. The localization of Haspin on 
mitotic chromosomes was observed by GFP signals from exogenously 
expressed Haspin-GFP prepared from mRNA addition to XEEs (Ghe-
noiu et al., 2013). For Haspin-GFP expression from mRNA, Haspin-
GFP mRNA was incubated in interphase XEEs at RT for 60 min at 
a concentration of 20 ng/µl (Fig.  3  A) or at multiple concentrations 
of 20, 40, and 60 ng/µl (Fig.  7  A). Afterward, demembraned sperm 
nuclei were added to allow for DNA replication. After the completion 
of DNA replication, an equal volume of CSF XEEs was added and 
incubated for 45 min for mitotic CSF XEEs with Haspin-GFP. DNA 
was stained with Hoechst 33342 dye (EMD Millipore), and the sam-
ples were mounted using Vectashield H-1000 medium (Vector Labora-
tories). All images were acquired using the Nikon Plan Apo 100×/1.4 
oil objective lens on a TE2000-U microscope (Nikon) with a Retiga 
SRV CCD camera (QImaging) operated by Volocity imaging software 
(PerkinElmer) at RT. Photoshop CS6 (Adobe) was used to process the 
obtained images from Volocity to show the signal intensities by adjust-
ing overall intensity range levels equally within independent experi-
ments without any gamma adjustments. Images were cropped and the 
resolution was adjusted to fit journal policy. Quantification of fluores-
cent signals was through ImageJ and Photoshop CS6 by measuring the 
signal intensity around CENP-A or SUMO2/3. Relative intensities of 
signals from indicated antibodies or GFP were normalized to CENP-A 
or SUMO2/3 signals. The means of the signal intensities from multi-
ple centromeres were calculated for each independent experiment, and 
the mean and SD of three independent experiments were determined 
for each assay. Statistical significance of the difference was calculated 
by t test of the means.
In vitro SUMOylation reaction
In vitro SUMOylation reaction was done by incubating 40 nM Aos1/
Uba2, 80 nM Ubc9, 40 nM PIASy, 24 µM SUMO2-GG, 4 µM S-tagged 
TOP2A CTD, and 2.5 mM ATP for 2 h at 25°C before binding onto 
S-agarose beads (EMD Millipore) overnight in 4°C for use in pull-
down assays. Non-SUMOylated CTD was prepared by incubating with 
the aforementioned mixture but without ATP.
Online supplemental material
Table S1 shows the summarized list of proteins that were pulled down 
specifically with SUMOylated TOP2A CTD and identified through 
LC-MS/MS analysis. Fig. S1 is the pull-down assay using recombinant 
S-tagged TOP2A CTD and CTD-SUMO through in vitro SUMOylation 
assay with SUMO2, which were bound to S-agarose beads and 
incubated in CSF XEEs. CTD-bound and CTD-SUMO-bound 
agarose beads were isolated, digested by SENP2 CD, and analyzed by 
immunoblotting for Pds5a and Pds5b. Neither Pds5a nor Pds5b were 
pulled down with either TOP2A CTD or SUMOylated TOP2A CTD. 
Fig. S2 shows the mitotic replicated centromeres cropped from Fig. 3 C 
to focus on a single pair of centromeres and signals of CENP-A, 
SUMO2/3, and H3T3p. A reduction in H3T3p signal intensity at the 
centromere is seen when dnUbc9 is added to inhibit SUMOylation. 
Online supplemental material is available at http ://www .jcb .org /cgi /
content /full /jcb .201511079 /DC1.
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